Archives

CHICAGO—Patients with oropharyngeal cancer pose no risk of passing HPV infection to their spouses or partners — according findings presented at the 2013 meeting of the American Society of Clinical Onc

CHICAGO—The first drug to hold advanced uveal melanoma in check — doubling progression-free survival — was announced at the 2013 American Society of Clinical Oncology meeting in Chicago. Dr Richard Ca

LUGANO, SWITZERLAND—Sarah Maxwell and Peter Goodwin report from the 2013 European Multidisciplinary Conference on Thoracic Oncology

LONDON—New and comprehensive data showing that millions of cases of breast cancer could be avoided by treating women at high risk of the disease — but who are not yet ill — with the class of drugs kno

WASHINGTON DC—Doctors taking the unusual step of combining two experimental drugs to treat cancers in patients who have mutated BRCA — the gene conferring susceptibility to breast, ovarian and some ot

WASHINGTON DC—Laboratory evidence that giving patients intermittent rather than continuous treatment with cancer drugs could help them overcome drug resistance in cancers such as melanoma was presente

WASHINGTON DC—A new blood test has detected drug-resistant mutations reliably in patients with gastrointestinal stromal tumour (GIST) helping to guide therapy when first-line drugs had failed. This wa

WASHINGTON DC—Gene expression and molecular pathways in head and neck cancer have been identified with reference to The Cancer Genome Atlas in research presented at the American Association for Cancer

WASHINGTON DC—Patients with metastatic breast cancer who are HER-2 positive could potentially be treated with the anti-HER-2 conjugated drug, trastuzumab-emtansine (T-DM1), alone — without needing to

WASHINGTON DC—A new type of immunotherapy has helped patients with advanced ovarian cancer who had no other therapeutic options. In a study reported to the 2013 conference of the American Association

CAMBRIDGE, UK—A new blood test promises quicker assessment of treatment efficacy in patients with metastatic breast cancer. Dr Dana Tsui and colleagues from the Cancer Research UK Cambridge Institute,

CAMBRIDGE, UK—A new blood test promises quicker assessment of treatment efficacy in patients with metastatic breast cancer. Dr Dana Tsui and colleagues from the Cancer Research UK Institute at Cambrid

Walking a dog most days could cut down your risk of having a recurrence of breast cancer, according to research presented at the St Gallen conference on Primary Therapy of Early Breast Cancer in Switz

ST GALLEN, SWITZERLAND—Bisphosphonates have an important part to play in managing breast cancer according to research reported at the 2013 St Gallen conference on “Primary Therapy of Early Breas

ST GALLEN, SWITZERLAND—The controversy about the effectiveness of mammographic screening was aired at the 2013 conference on “Primary Therapy of Early Breast Cancer” by Dr Donald Berry of

ORLANDO, FLORIDA—Patients with low-risk prostate cancer are more likely to die with their disease than of it, according to Dr Ayal Aizer from the Brigham and Women’s Hospital, the Dana-Farber Ca

ORLANDO, FLORIDA—Men over 75 were safely and effectively treated for their metastatic castration-resistant prostate cancer with the androgen receptor inhibitor enzalutamide in the Phase III AFFIRM stu

ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Sympo

ORLANDO, FLORIDA—Patients receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from the usual 36 months — but have fewer side effec

ORLANDO, FLORIDA—Patients with low-risk prostate cancer are more likely to die with their disease than of it, according to Dr Ayal Aizer from the Brigham and Women’s Hospital,

ORLANDO, FLORIDA—Patients receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from the usual 36 months

Headlines: – Pr James Versalovic : Microbial ecology of the gastrointestinal tract – Pr Francisco Guarner : Gut microbiota and the immune system education – Pr Fernando Aspiroz : Gut

Other headlines: – CABG should remain the standard of care for patients with multivessel coronary artery disease – Determinants of weight gain from intensive glucose-lowering treatment &#8

Other headlines: – Raised incidence of HPV-associated cancers in the past 35 years in the United States. – Two new anticoagulants for the extended treatment of patients with unprovoked ven

Other headlines: – Deep Brain Stimulation proved effective on motor skills and quality of life in patients at early stages of Parkinson’s disease. – Folic acid supplementation during